We are live on ! Find out more
EV

Eclipse Ventures Portfolio holdings

AUM $2.57B
This Fund
S&P 500
This Quarter Est. Return
+30.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$599M
AUM Growth
Cap. Flow
+$635M
Cap. Flow %
106.02%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ENVX icon
Enovix
ENVX
+$487M
2
OWLT icon
Owlet
OWLT
+$109M
3
LHDX
Lucira Health, Inc. Common Stock
LHDX
+$39.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 79.62%
2 Healthcare 20.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENVX icon
1
Enovix
ENVX
$737M
$477M 79.62%
+20,095,152
New +$487M
OWLT icon
2
Owlet
OWLT
$146M
$68.5M 11.43%
+2,035,167
New +$109M
LHDX
3
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$53.6M 8.95%
+6,223,795
New +$39.6M

Similar funds

Eclipse Ventures's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Eclipse Ventures, which disclosed 3 positions worth $599M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Enovix: 20,095,152 shares worth $477M.

By sector, the portfolio is most concentrated in Industrials at 80% of assets, followed by Healthcare.

  • Eclipse Ventures's largest Q4 2021 buy was Enovix: 20,095,152 shares worth $477M.
  • Eclipse Ventures's ten largest holdings make up 100% of its $599M portfolio in Q4 2021.
  • Eclipse Ventures disclosed 3 positions in Q4 2021, its first 13F filing on record.

Based on Eclipse Ventures's 13F filing for Q4 2021, filed 9 Feb 2022.